KBR Stock Price, News & Analysis

KBR announced that its joint venture Xandar, LLC has secured a $4.8 billion contract with the National Air and Space Intelligence Center for the NOVASTAR program, extending to 2033. Xandar will offer research and development support for various systems and software to enhance scientific and technical intelligence production for the U.S. Air Force and the Department of Defense. The partnership combines KBR's extensive expertise with NASK's agile capabilities, addressing evolving security challenges.

KBR announced a quarterly dividend of $0.12 per share on August 17, 2022. This dividend will be payable on October 14, 2022, to stockholders of record by September 15, 2022. With approximately 28,000 employees across 34 countries, KBR delivers science, technology, and engineering solutions globally. The company emphasizes its commitment to providing consistent delivery and predictable results for its customers.

On August 3, 2022, KBR and McDermott International announced a global licensing agreement to jointly provide integrated solutions utilizing KBR's proprietary ammonia technologies. This collaboration focuses on producing renewable and low-carbon ammonia, essential for decarbonization efforts, as it can serve as carbon-free fertilizers or energy carriers. The partnership aims to leverage KBR's advanced technology and McDermott's global execution capabilities for efficient low-carbon ammonia projects. Together, they will explore modularized execution concepts to enhance project efficiency.

KBR reported strong Q2 2022 results with a net income of $94 million and diluted EPS of $0.61, marking a significant improvement from a net loss of $149 million in Q2 2021. Revenue increased by 5% to $1.6 billion. Adjusted EBITDA stood at $186 million, with a margin of 12%. The company generated $125 million in operating cash flow and added $232 million in deployable free cash. KBR is focused on high-barrier markets, recently acquiring VIMA Group and expanding its investment in Mura Technology.

KBR announced it will lead the development of self-defending, self-recovering cyber defense concepts for the UK Ministry of Defence through its subsidiary, Frazer-Nash Consultancy. This three-year project, part of the Autonomous Resilient Cyber Defence initiative, will utilize artificial intelligence and machine learning to create cyber defense strategies tested against simulated military attacks. KBR's expertise in cyber security spans over two decades, and the project aims to enhance the MOD's resilience against cyber threats.

KBR has been selected as a major partner for Axiom Space under NASA's xEVAS contract to develop next-gen spacesuits. This contract, valued at $3.5 billion, spans until 2034. It encompasses design, testing, and manufacturing services for spacesuits aimed at lunar missions and future Mars exploration. KBR has over 25 years of experience in spacesuit development, continuing its legacy of supporting space missions. This collaboration marks a significant milestone in KBR's commitment to advancing human spaceflight capabilities.

KBR, Inc. (NYSE: KBR) has announced a conference call to discuss its second quarter 2022 financial results on August 2, 2022, at 7:30 a.m. Central Time. The company will issue its earnings release and presentation prior to the call, both of which will be available on KBR's website. The conference call will be webcast live, with a replay accessible afterward via the website or by telephone. KBR employs approximately 28,000 people across 34 countries, delivering diverse engineering solutions globally.

KBR (NYSE: KBR) has secured a $20 million contract to expand its health and human performance research for the 711th Human Performance Wing at the Air Force Research Laboratory over a period of 3 years. This cost-plus-fixed-fee agreement enhances KBR's existing R&D initiatives, focusing on airman readiness medical research. The company will utilize its expertise at Wright-Patterson Air Force Base to study the biomedical impacts on airmen, including cognitive performance and aerospace physiology.